Geode Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.24M | Sell |
|
|||||
|
2025
Q2 | $4.98M | Buy |
|
|||||
|
2025
Q1 | $13.3M | Buy |
|
|||||
|
2024
Q4 | $22M | Buy |
|
|||||
|
2024
Q3 | $29.9M | Buy |
|
|||||
|
2024
Q2 | $34.5M | Buy |
|
|||||
|
2024
Q1 | $40.5M | Buy |
|
|||||
|
2023
Q4 | $43.7M | Buy |
|
|||||
|
2023
Q3 | $25.4M | Buy |
|
|||||
|
2023
Q2 | $23.5M | Buy |
|
|||||
|
2023
Q1 | $19.8M | Buy |
|
|||||
|
2022
Q4 | $21.6M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Buy |
|
|||||
|
2022
Q2 | $11.1M | Buy |
|
|||||
|
2022
Q1 | $11.9M | Sell |
|
|||||
|
2021
Q4 | $16.5M | Buy |
|
|||||
|
2021
Q3 | $22.5M | Buy |
|
|||||
|
2021
Q2 | $32.9M | Buy |
|
|||||
|
2021
Q1 | $30.5M | Buy |
|
|||||
|
2020
Q4 | $32.9M | Buy |
|
|||||
|
2020
Q3 | $12.1M | Sell |
|
|||||
|
2020
Q2 | $11.5M | Buy |
|
|||||
|
2020
Q1 | $7.25M | Buy |
|
|||||
|
2019
Q4 | $10.7M | Buy |
|
|||||
|
2019
Q3 | $5.41M | Buy |
|
|||||
|
2019
Q2 | $6.66M | Buy |
|
|||||
|
2019
Q1 | $5.81M | Buy |
|
|||||
|
2018
Q4 | $4.4M | Buy |
|
|||||
|
2018
Q3 | $5.47M | Buy |
|
|||||
|
2018
Q2 | $2.71M | Buy |
|
|||||
|
2018
Q1 | $1.51M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $183K | Hold |
|
|||||
|
2017
Q2 | $195K | Sell |
|
|||||
|
2017
Q1 | $268K | Buy |
|
|||||
|
2016
Q4 | $797K | Buy |
|
|||||
|
2016
Q3 | $1.18M | Buy |
|
|||||
|
2016
Q2 | $768K | Buy |
|
|||||
|
2016
Q1 | $607 | Sell |
|
|||||
|
2015
Q4 | $930K | Buy |
|
|||||
|
2015
Q3 | $744K | Buy |
|
|||||
|
2015
Q2 | $145K | Buy |
|